左归丸对庆大霉素诱导耳肾损伤大鼠模型JNK/c-Jun通路的影响及机制
|
摘要
目的：探讨左归丸对庆大霉素诱导耳肾损伤大鼠模型JJNK通路的影响及机制。
方法：
(1)将12只SPF级雄性Wistar大鼠适应性喂养1周后,随机分为空白对照组、庆大霉素组。每组6只。空白对照组腹腔注射生理盐水2.5ml·kg-1·d-1,庆大霉素组腹腔注射硫酸庆大霉素100mg·kg-1·d-1。每日根据体重调整给药剂量。2组大鼠连续给药10d。分别在给药前和给药后检测大鼠听力ABR阈值、尿NAG酶值,在实验结束取耳蜗和肾脏标本进行HE染色,在光镜下观察耳蜗和肾脏病理变化。
(2)将18只SPF级Wistar大鼠适应性喂养1周后随机分为3组：空白对照组,模型组和左归丸组。每组6只。空白对照组腹腔注射生理盐水2.5ml·kg-1·d-1,模型组腹腔注射硫酸庆大霉素100mg·kg-1·d-1,左归丸组腹腔注射硫酸庆大霉素100mg·kg-1·d-1和灌胃左归丸水溶液10g·kg-1·d-1。每日根据体重调整给药剂量。3组大鼠连续给药10d。分别在给药前和给药后检测大鼠听力ABR阈值、尿NAG酶值、大鼠体重变化。实验结束后,测量大鼠肾脏指数,留取血液检测Scr、BUN。留取耳蜗和肾脏标本光镜和电镜下观察病理变化。
(3)将72只SPF级Wistar大鼠适应性喂养1周后随机分为4组：空白对照组,模型组、SP600125组和左归丸组。每组18只。空白对照组腹腔注射生理盐水2.5ml·kg-1·d-1;模型组腹腔注射硫酸庆大霉素100mg·kg-1·d-1; SP600125组左侧腹腔注射硫酸庆大霉素100mg·kg-1·d-1,2h后右侧腹腔注射SP60012515mg·kg-1·d-1;左归丸组腹腔注射硫酸庆大霉素100mg·kg-1·d-1和灌胃左归丸水溶液10g·kg-1·d-1。每日根据体重调整给药剂量。4组大鼠连续给药10d。实验结束后,留取耳蜗和肾脏标本,以免疫组化方法、免疫印迹杂交方法、实时定量PCR方法检测JJNK、p-JNK、c-Jun的表达和蛋白、基因的含量。
结果：
(1)庆大霉素组大鼠腹腔注射100mg·kg-1·d-1×10d后,听力ABR阈值和尿NAG酶值明显升高,与空白对照组相比,具有统计学差异(P<0.01)。大鼠耳蜗、肾脏病理形态比较：空白对照组螺旋器毛细胞完整无缺失,排列整齐；肾脏小管、间质无特殊改变。而庆大霉素组螺旋器毛细胞出现丢失、变性、排列不规则；肾小管出现炎性细胞浸润,并出现细胞肿胀、变性。
(2)3组大鼠ABR阈值、尿NAG酶、血Scr与BUN、肾脏指数结果：与空白对照组相比,模型组ABR阈值、尿NAG酶、血Scr与BUN、肾脏指数值明显升高,具有统计学差异(P<0.01)；与模型组相比,左归丸组ABR阈值、尿NAG酶、血Scr与BUN、肾脏指数值明显下降,具有统计学差异(P<0.05或P<0.01)。大鼠体重结果：与空白组相比,模型组大鼠体重数值明显降低,具有统计学差异(P<0.01)；与模型组相比,左归丸组大鼠体重数值得到升高,具有统计学差异(P<0.05)。耳蜗、肾脏HE染色病理结果：空白对照组耳蜗螺旋器毛细胞无缺失,排列整齐；肾脏小管、间质无特殊改变。而模型组耳蜗螺旋器毛细胞出现核固缩、核破裂,毛细胞丢失严重；肾脏小管上皮细胞出现肿胀、变性和少量坏死。左归丸组耳蜗毛细胞有少量丢失,排列尚可；肾脏小管上皮细胞出现轻微肿胀、变性。透射电镜超微病理结果：空白对照组耳蜗线粒体、粗面内质网结构未发生明显改变；近曲肾小管上皮细胞整体结构正常,基底面有排列整齐的质膜内褶,胞浆及质膜内褶间分布众多线粒体。模型组耳蜗胞浆溶酶体增多,部分出现空泡化；近曲肾小管上皮细胞游离面局部微绒毛脱落,胞浆内多处巨大囊泡扩张。左归丸组耳蜗毛细胞形态结构基本正常,部分胞浆空泡化；近曲肾小管微绒毛排列整齐,胞浆内少量囊泡病变,管腔内有少量絮状物。
(3) TUNEL细胞凋亡结果：空白对照组耳蜗和肾脏有少量凋亡细胞,模型组耳蜗和肾脏TUNEL阳性细胞数目明显增多具有统计学差异(P<0.01)；与模型组比较,左归丸组和SP600125组耳蜗和肾脏TUNEL阳性细胞数目明显减少,具有显著统计学差异(P<0.01)。免疫组化结果：空白对照组耳蜗和肾脏JNK、p-JNK、c-Jun蛋白表达较少。与空白对照组相比,模型组JNK、p-JNK、c-Jun蛋白有大量表达,具有显著统计学差异(P<0.01)。耳蜗主要集中在螺旋器、血管纹、螺旋神经节部位表达；肾脏主要集中在肾小管部位。与模型组相比,左归丸组和SP600125组表达减少,具有显著统计学差异(P<0.01)。免疫印迹杂交结果：与空白组相比,模型组耳蜗和肾脏JNK、p-JNK、c-Jun蛋白表达显著升高,具有显著统计学差异(P<0.01)；与模型组相比,左归丸组SP600125组耳蜗和肾脏JNK、p-JNK、c-Jun蛋白表达明显下降,具有显著统计学差异(P<0.01)。实时定量PCR结果：与空白组相比,模型组内耳和肾脏JNK mRNA和c-Jun mRNA表达显著升高(P<0.01)；与模型组相比,SP600125组JNK mRNA和c-Jun mRNA表达显著下调(P<0.01)
结论：
(1)大鼠腹腔注射庆大霉素100mg·kg-1·d-1×10d可以成功建立耳肾损伤模型。
(2)左归丸能够保护耳肾损伤大鼠的听力和肾功能,能够改善耳肾损伤大鼠耳蜗和肾脏病理状况,能够减轻病理性细胞凋亡状态。
(3) JNK/c-Jun通路对庆大霉素诱导的耳肾损伤模型中细胞凋亡起重要调控作用,激活的JNK/c-Jun通路促使病理性细胞凋亡的发生,并参与庆大霉素诱导的耳肾损伤。
(4)左归丸能够抑制JNK通路在耳肾损伤大鼠模型的激活。左归丸对耳肾损伤大鼠的保护作用可能与抑制JNK通路的激活有关。
Objective:To discussion the Intervention of Zuogui pill on JNK/c-Jun pathway of the gentamicin-induced Oto-renal injury in rat model and the Mechanism.
Methods:
(1)12male Wistar rats were divided randomly into control group, and Gentamic in sulfate (GM) model group. The control group was given intraperitoneal injection of0.9%saline2.5ml·kg-1·d-1, GM group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1. Two groups of rats administered for10consecutive days. Detection of ABR threshold and NAG enzyme values of rats administered before and after administration, at the end of the experiment to take cochlea and kidney specimens were stained with HE, cochlea and kidney pathological changes in the light microscope.
(2)18male Wistar rats were divided randomly into control group, model group and Zuogui pill group. The control group was given intraperitoneal injection of0.9%saline2.5ml·kg-1·d-1, model group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1, Zuogui pill group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1and gavage Zuogui pill aqueous solution10g·kg-1·d-1. Three groups of rats administered for10consecutive days. Detected before drug administration and after ABR threshold, urinary NAG enzyme values, changes in body weight of rats. After the end of the experiment, the measurement of the index of the rat kidney specimens from blood tests Scr, BUN. Specimens of pathological changes in light and electron microscopy of the cochlea and kidney specimens.
(3)72male Wistar rats were divided randomly into control group, model group, Sp600125group and Zuogui pill group. The control group was given intraperitoneal injection of0.9%saline2.5ml·kg-1·d-1, model group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1, SP600125group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1and intraperitoneal injection of SP60012515mg·kg-1·d-1, Zuogui pill group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1and gavage Zuogui pill aqueous solution10g·kg-1·d-1. Four groups of rats administered for10consecutive days. After the end of the experiment,the specimens from the cochlea and kidney specimens, TUNEL, immunohistochemistry, Western blot hybridization, and real-time PCR method to detect JNK, p-JNK, c-Jun expression and protein, gene content.
Results:
(1) GM group by intraperitoneal injection of gentamicin100mg·kg-1·d-×10d, the hearing threshold of ABR and urinary NAG enzyme values significantly higher, compared with the control group,with a statistically significant difference (P<0.01).Rat cochlea and kidney pathological comparison:Control group of corti full without missing hair cells, neat rows; Renal tubules and interstitial no special change. GM group of organ of corti appear hair loss, degeneration, irregular arrangement; Renal tubule in inflammatory cell infiltration, and cell swelling and degeneration.
(2) Three groups ABR threshold, urinary NAG enzyme, blood Scr and BUN, kidney index results:compared with the control group, the model group ABR threshold, urinary NAG enzyme, blood Scr and BUN, kidney index was significantly higher, with a significant difference (P<0.01); compared with the model group, the Zuogui pill groups is decreased significantly, with a significant difference (P<0.05and P<0.01). Body weight of rats results:After administration, compared with the control group rats, the weight value is significantly lower, with a significant difference (P<0.01); Compared with the model group, Zuogui pill group rats weight values increased, with a statistically significant difference (P<0.05). Cochlea, kidney HE staining pathological findings:Control group in the cochlea corti hair cell loss, neat rows; And the model group the cochlea corti hair a nuclear pyknosis, karyorrhexis, hair loss is serious; Zuogui pill group of cochlear hair cells loss, a small amount of an acceptable arrangement. Control group kidney tubules and interstitial no special change; And model groups renal tubular epithelial cell swelling, degeneration and small amounts of necrosis; Zuogui pill group of renal tubular epithelial cells slight swelling and degeneration. Transmission electron microscopy results:Control group cochlea mitochondria, rough endoplasmic reticulum structure did not change significantly; Proximal tubular epithelial cells in the overall structure of the normal, basal surface of the plasma membrane are arranged neatly tuck, tuck between the cytoplasm and plasma membrane distribution of numerous mitochondria. Model group cytoplasmic lysosomes cochlea, part of the vacuoles appear; Proximal tubular epithelial cells localized free surface microvilli, intracytoplasmic vesicles many huge expansion. Zuogui pill group cochlear hair cell morphology was normal, and some cytoplasmic vacuoles; Proximal tubular microvilli neat, small cytoplasmic vesicle lesions lumen of a small amount of floe.
(3) Results of TUNEL Cell apoptosis:Control group cochlea and kidney have few apoptotic cells, the model group cochlea and kidney of TUNEL-positive cells increased significantly in the number with a statistically significant difference (P<0.01); The the Zuogui pill group and SP600125group cochlea and kidney of TUNEL-positive cells significantly reduced the number compared with the model group, with statistically significant differences (P<0.01). Immunohisto-chemical results:Compared with the control group, model group, JNK, c-Jun protein expression of p-JNK, a statistically significant difference (P<0.01); Compared with the model group, The Zuoguipill group and SP600125group JNK, p-JNK, c-Jun protein expression was significantly decreased, with a statistically significant difference (P<0.01). Western blot hresults:Compared with the control group, The model group cochlea and kidney of JNK, p-JNK c-Jun protein expression was significantly increased, with a statistically significant difference (P<0.01); Compared with the model group, the the SP600125group cochlea and kidney of Zuogui pill group of JNK, c-Jun protein expression was significantly decreased p-the JHK, a statistically significant difference (P<0.01). Real-time PCR results:Compared with the control group, the model group, the inner ear and kidney JNK mRNA and c-Jun mRNA expression was significantly higher (P<0.01); Compared with the model group, Zuogui pill group and SP600125JNK mRNA and c-Jun mRNA expression was significantly lower (P<0.01).
Conclusions:
(1) The intraperitoneal injection100mg·kg-1·d-1gentamicin oto-renal injury model can be successfully established.
(2) Zuogui pill able to protect oto-renal injury in rats hearing and kidney function, to improve oto-renal injury in rat cochlea and kidney pathological conditions, can reduce the pathological apoptosis state.
(3) JNK/c-Jun pathway play an important regulatory role in apoptosis in the ear gentamicin-induced renal injury model. Activation of JNK/c-Jun pathway to promote the pathological cell apoptosis, and participate in gentamicin-induced oto-renal injury.
(4) The protective effect of Zuogui pill oto-renal injury in rats may be related to the inhibition of the activation of the JNK pathway. Zuogui pill able to inhibit the activation of the JNK pathway in oto-renal injury in rats model.
方法：
(1)将12只SPF级雄性Wistar大鼠适应性喂养1周后,随机分为空白对照组、庆大霉素组。每组6只。空白对照组腹腔注射生理盐水2.5ml·kg-1·d-1,庆大霉素组腹腔注射硫酸庆大霉素100mg·kg-1·d-1。每日根据体重调整给药剂量。2组大鼠连续给药10d。分别在给药前和给药后检测大鼠听力ABR阈值、尿NAG酶值,在实验结束取耳蜗和肾脏标本进行HE染色,在光镜下观察耳蜗和肾脏病理变化。
(2)将18只SPF级Wistar大鼠适应性喂养1周后随机分为3组：空白对照组,模型组和左归丸组。每组6只。空白对照组腹腔注射生理盐水2.5ml·kg-1·d-1,模型组腹腔注射硫酸庆大霉素100mg·kg-1·d-1,左归丸组腹腔注射硫酸庆大霉素100mg·kg-1·d-1和灌胃左归丸水溶液10g·kg-1·d-1。每日根据体重调整给药剂量。3组大鼠连续给药10d。分别在给药前和给药后检测大鼠听力ABR阈值、尿NAG酶值、大鼠体重变化。实验结束后,测量大鼠肾脏指数,留取血液检测Scr、BUN。留取耳蜗和肾脏标本光镜和电镜下观察病理变化。
(3)将72只SPF级Wistar大鼠适应性喂养1周后随机分为4组：空白对照组,模型组、SP600125组和左归丸组。每组18只。空白对照组腹腔注射生理盐水2.5ml·kg-1·d-1;模型组腹腔注射硫酸庆大霉素100mg·kg-1·d-1; SP600125组左侧腹腔注射硫酸庆大霉素100mg·kg-1·d-1,2h后右侧腹腔注射SP60012515mg·kg-1·d-1;左归丸组腹腔注射硫酸庆大霉素100mg·kg-1·d-1和灌胃左归丸水溶液10g·kg-1·d-1。每日根据体重调整给药剂量。4组大鼠连续给药10d。实验结束后,留取耳蜗和肾脏标本,以免疫组化方法、免疫印迹杂交方法、实时定量PCR方法检测JJNK、p-JNK、c-Jun的表达和蛋白、基因的含量。
结果：
(1)庆大霉素组大鼠腹腔注射100mg·kg-1·d-1×10d后,听力ABR阈值和尿NAG酶值明显升高,与空白对照组相比,具有统计学差异(P<0.01)。大鼠耳蜗、肾脏病理形态比较：空白对照组螺旋器毛细胞完整无缺失,排列整齐；肾脏小管、间质无特殊改变。而庆大霉素组螺旋器毛细胞出现丢失、变性、排列不规则；肾小管出现炎性细胞浸润,并出现细胞肿胀、变性。
(2)3组大鼠ABR阈值、尿NAG酶、血Scr与BUN、肾脏指数结果：与空白对照组相比,模型组ABR阈值、尿NAG酶、血Scr与BUN、肾脏指数值明显升高,具有统计学差异(P<0.01)；与模型组相比,左归丸组ABR阈值、尿NAG酶、血Scr与BUN、肾脏指数值明显下降,具有统计学差异(P<0.05或P<0.01)。大鼠体重结果：与空白组相比,模型组大鼠体重数值明显降低,具有统计学差异(P<0.01)；与模型组相比,左归丸组大鼠体重数值得到升高,具有统计学差异(P<0.05)。耳蜗、肾脏HE染色病理结果：空白对照组耳蜗螺旋器毛细胞无缺失,排列整齐；肾脏小管、间质无特殊改变。而模型组耳蜗螺旋器毛细胞出现核固缩、核破裂,毛细胞丢失严重；肾脏小管上皮细胞出现肿胀、变性和少量坏死。左归丸组耳蜗毛细胞有少量丢失,排列尚可；肾脏小管上皮细胞出现轻微肿胀、变性。透射电镜超微病理结果：空白对照组耳蜗线粒体、粗面内质网结构未发生明显改变；近曲肾小管上皮细胞整体结构正常,基底面有排列整齐的质膜内褶,胞浆及质膜内褶间分布众多线粒体。模型组耳蜗胞浆溶酶体增多,部分出现空泡化；近曲肾小管上皮细胞游离面局部微绒毛脱落,胞浆内多处巨大囊泡扩张。左归丸组耳蜗毛细胞形态结构基本正常,部分胞浆空泡化；近曲肾小管微绒毛排列整齐,胞浆内少量囊泡病变,管腔内有少量絮状物。
(3) TUNEL细胞凋亡结果：空白对照组耳蜗和肾脏有少量凋亡细胞,模型组耳蜗和肾脏TUNEL阳性细胞数目明显增多具有统计学差异(P<0.01)；与模型组比较,左归丸组和SP600125组耳蜗和肾脏TUNEL阳性细胞数目明显减少,具有显著统计学差异(P<0.01)。免疫组化结果：空白对照组耳蜗和肾脏JNK、p-JNK、c-Jun蛋白表达较少。与空白对照组相比,模型组JNK、p-JNK、c-Jun蛋白有大量表达,具有显著统计学差异(P<0.01)。耳蜗主要集中在螺旋器、血管纹、螺旋神经节部位表达；肾脏主要集中在肾小管部位。与模型组相比,左归丸组和SP600125组表达减少,具有显著统计学差异(P<0.01)。免疫印迹杂交结果：与空白组相比,模型组耳蜗和肾脏JNK、p-JNK、c-Jun蛋白表达显著升高,具有显著统计学差异(P<0.01)；与模型组相比,左归丸组SP600125组耳蜗和肾脏JNK、p-JNK、c-Jun蛋白表达明显下降,具有显著统计学差异(P<0.01)。实时定量PCR结果：与空白组相比,模型组内耳和肾脏JNK mRNA和c-Jun mRNA表达显著升高(P<0.01)；与模型组相比,SP600125组JNK mRNA和c-Jun mRNA表达显著下调(P<0.01)
结论：
(1)大鼠腹腔注射庆大霉素100mg·kg-1·d-1×10d可以成功建立耳肾损伤模型。
(2)左归丸能够保护耳肾损伤大鼠的听力和肾功能,能够改善耳肾损伤大鼠耳蜗和肾脏病理状况,能够减轻病理性细胞凋亡状态。
(3) JNK/c-Jun通路对庆大霉素诱导的耳肾损伤模型中细胞凋亡起重要调控作用,激活的JNK/c-Jun通路促使病理性细胞凋亡的发生,并参与庆大霉素诱导的耳肾损伤。
(4)左归丸能够抑制JNK通路在耳肾损伤大鼠模型的激活。左归丸对耳肾损伤大鼠的保护作用可能与抑制JNK通路的激活有关。
Objective:To discussion the Intervention of Zuogui pill on JNK/c-Jun pathway of the gentamicin-induced Oto-renal injury in rat model and the Mechanism.
Methods:
(1)12male Wistar rats were divided randomly into control group, and Gentamic in sulfate (GM) model group. The control group was given intraperitoneal injection of0.9%saline2.5ml·kg-1·d-1, GM group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1. Two groups of rats administered for10consecutive days. Detection of ABR threshold and NAG enzyme values of rats administered before and after administration, at the end of the experiment to take cochlea and kidney specimens were stained with HE, cochlea and kidney pathological changes in the light microscope.
(2)18male Wistar rats were divided randomly into control group, model group and Zuogui pill group. The control group was given intraperitoneal injection of0.9%saline2.5ml·kg-1·d-1, model group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1, Zuogui pill group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1and gavage Zuogui pill aqueous solution10g·kg-1·d-1. Three groups of rats administered for10consecutive days. Detected before drug administration and after ABR threshold, urinary NAG enzyme values, changes in body weight of rats. After the end of the experiment, the measurement of the index of the rat kidney specimens from blood tests Scr, BUN. Specimens of pathological changes in light and electron microscopy of the cochlea and kidney specimens.
(3)72male Wistar rats were divided randomly into control group, model group, Sp600125group and Zuogui pill group. The control group was given intraperitoneal injection of0.9%saline2.5ml·kg-1·d-1, model group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1, SP600125group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1and intraperitoneal injection of SP60012515mg·kg-1·d-1, Zuogui pill group was given intraperitoneal injection of gentamicin sulfate100mg·kg-1·d-1and gavage Zuogui pill aqueous solution10g·kg-1·d-1. Four groups of rats administered for10consecutive days. After the end of the experiment,the specimens from the cochlea and kidney specimens, TUNEL, immunohistochemistry, Western blot hybridization, and real-time PCR method to detect JNK, p-JNK, c-Jun expression and protein, gene content.
Results:
(1) GM group by intraperitoneal injection of gentamicin100mg·kg-1·d-×10d, the hearing threshold of ABR and urinary NAG enzyme values significantly higher, compared with the control group,with a statistically significant difference (P<0.01).Rat cochlea and kidney pathological comparison:Control group of corti full without missing hair cells, neat rows; Renal tubules and interstitial no special change. GM group of organ of corti appear hair loss, degeneration, irregular arrangement; Renal tubule in inflammatory cell infiltration, and cell swelling and degeneration.
(2) Three groups ABR threshold, urinary NAG enzyme, blood Scr and BUN, kidney index results:compared with the control group, the model group ABR threshold, urinary NAG enzyme, blood Scr and BUN, kidney index was significantly higher, with a significant difference (P<0.01); compared with the model group, the Zuogui pill groups is decreased significantly, with a significant difference (P<0.05and P<0.01). Body weight of rats results:After administration, compared with the control group rats, the weight value is significantly lower, with a significant difference (P<0.01); Compared with the model group, Zuogui pill group rats weight values increased, with a statistically significant difference (P<0.05). Cochlea, kidney HE staining pathological findings:Control group in the cochlea corti hair cell loss, neat rows; And the model group the cochlea corti hair a nuclear pyknosis, karyorrhexis, hair loss is serious; Zuogui pill group of cochlear hair cells loss, a small amount of an acceptable arrangement. Control group kidney tubules and interstitial no special change; And model groups renal tubular epithelial cell swelling, degeneration and small amounts of necrosis; Zuogui pill group of renal tubular epithelial cells slight swelling and degeneration. Transmission electron microscopy results:Control group cochlea mitochondria, rough endoplasmic reticulum structure did not change significantly; Proximal tubular epithelial cells in the overall structure of the normal, basal surface of the plasma membrane are arranged neatly tuck, tuck between the cytoplasm and plasma membrane distribution of numerous mitochondria. Model group cytoplasmic lysosomes cochlea, part of the vacuoles appear; Proximal tubular epithelial cells localized free surface microvilli, intracytoplasmic vesicles many huge expansion. Zuogui pill group cochlear hair cell morphology was normal, and some cytoplasmic vacuoles; Proximal tubular microvilli neat, small cytoplasmic vesicle lesions lumen of a small amount of floe.
(3) Results of TUNEL Cell apoptosis:Control group cochlea and kidney have few apoptotic cells, the model group cochlea and kidney of TUNEL-positive cells increased significantly in the number with a statistically significant difference (P<0.01); The the Zuogui pill group and SP600125group cochlea and kidney of TUNEL-positive cells significantly reduced the number compared with the model group, with statistically significant differences (P<0.01). Immunohisto-chemical results:Compared with the control group, model group, JNK, c-Jun protein expression of p-JNK, a statistically significant difference (P<0.01); Compared with the model group, The Zuoguipill group and SP600125group JNK, p-JNK, c-Jun protein expression was significantly decreased, with a statistically significant difference (P<0.01). Western blot hresults:Compared with the control group, The model group cochlea and kidney of JNK, p-JNK c-Jun protein expression was significantly increased, with a statistically significant difference (P<0.01); Compared with the model group, the the SP600125group cochlea and kidney of Zuogui pill group of JNK, c-Jun protein expression was significantly decreased p-the JHK, a statistically significant difference (P<0.01). Real-time PCR results:Compared with the control group, the model group, the inner ear and kidney JNK mRNA and c-Jun mRNA expression was significantly higher (P<0.01); Compared with the model group, Zuogui pill group and SP600125JNK mRNA and c-Jun mRNA expression was significantly lower (P<0.01).
Conclusions:
(1) The intraperitoneal injection100mg·kg-1·d-1gentamicin oto-renal injury model can be successfully established.
(2) Zuogui pill able to protect oto-renal injury in rats hearing and kidney function, to improve oto-renal injury in rat cochlea and kidney pathological conditions, can reduce the pathological apoptosis state.
(3) JNK/c-Jun pathway play an important regulatory role in apoptosis in the ear gentamicin-induced renal injury model. Activation of JNK/c-Jun pathway to promote the pathological cell apoptosis, and participate in gentamicin-induced oto-renal injury.
(4) The protective effect of Zuogui pill oto-renal injury in rats may be related to the inhibition of the activation of the JNK pathway. Zuogui pill able to inhibit the activation of the JNK pathway in oto-renal injury in rats model.
引文
[1]刘双月,王爱梅,许涛.阿米卡星致毒豚鼠耳蜗中p-JNK表达增强[J].基础医学与临床,2011,31(8)：889-893
[2]薛秋红,陈佳,龚树生,等.JNK信号通道在强噪声诱导豚鼠耳蜗细胞凋亡的作用[J].临床耳鼻咽喉头颈外科杂志,2009,24：1138-1142
[3]Meng LQ, Tang JW, Wang Y, et al. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy[J]. Br J Pharmacol,2011,162 (8):1805-1818
[4]李嫚,王汉民,李苏童,等.缺血后处理对大鼠肾脏缺血再灌注损伤P38MAPK和JNK的影响[J].医学临床研究,2008,25(7)：1170-1173
[5]Hou X, Shen YH, Li C, et al. PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity[J]. Biochem Biophys Res Commun, 2010,394(3):653-659
[6]Ohashi N, Urushihara M, Satou R, et al. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygenspecies-ERK/JNK pathways [J]. Hypertens Res,2010,33(11):1174-1181
[7]王小琴,袁军,马晓红,等.左归丸对5/6肾大部切除模型并肾性骨病大鼠骨代谢指标的影响[J].中国中西医结合肾病杂志,2012,13(7)：584-586
[8]贾琳琳,杨浩,付纯芳,等.刺五加注射液对豚鼠庆大霉素耳毒性拮抗作用的初步研究[J].中成药,2008,30(5)：763
[9]王枫,赵乌兰,黄宇佳.补肾剂对耳聋豚鼠耳蜗细胞凋亡的影响[J].浙江中医药大学学报,2008,32(4)：438
[10]王爱梅,杨浩,宝东艳,等.丹参注射液对庆大霉素耳中毒豚鼠耳蜗NOS异构体表达的影响[J].中国应用生理学杂志,2011,27,(2)：247
[11]Ozbek E, Cekmen M, Ilbey YO, et al. Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways[J]. Renal Failure,2009,31 (5):381-392
[12]陈香美.肾脏病学实验技术操作规程[M].北京：人民军医出版社,2011：197
[13]李荣山.现代肾脏病实验技术[M].北京：军事医学科学出版社,2006：103-104
[14]刘冬娟,赖亚新,徐彦平,等.庆大霉素致大鼠肾近端小管上皮细胞凋亡的超微结构研究[J].中国药物警戒,2009,6(12)：709-712
[15]延瑞喆.简述药物引起的耳毒性及防治措施[J].中国药事,2012,26(12)：1416
[16]Xie J, Talaska AE, Schacht J. New developments In aminogl-ycoside therapy and ototoxicity [J]. Hearing Research,2011, 281 (1-2):28-37
[17]Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycosid-e ototoxicity and targets of hair cell protection[J]. Int J Otolaryngol,2011:1-19
[18]丁大连,亓卫东,张梅,等.顺铂及其耳毒性[J].中华耳科学杂志,2008,6(2)：125-133
[19]薛翔,宫丽崑,任进.药物性肾损伤机制研究进展[J].药学学报,2010,45(10)：1199-1204
[20]李昱,王爱梅.氨基糖甙类抗生素耳毒性的研究进展[J].医学综述, 2008,14(3)：459-461
[21]Forge A, Schacht J. Aminoglyciside antibiotics [J]. Audiol Neuro-otol,2000,5(1):3-2
[22]高文元,迟放鲁.临床听觉生理学[M].北京：人民军医出版社,2004：236
[23]Karasawa T, Wang Q, David LL, et al. CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity[J]. Cell Death Dis,2010,1(11):102
[24]孔维佳.耳鼻咽喉头颈外科学[M].北京：人民卫生出版社,2008：162
[25]李兴启.听觉诱发反应及应用[M].北京：人民军医出版社,2007：122
[26]叶任高,许韩师.尿溶菌酶和N-乙酰-β-D-氨基葡萄糖苷酶测定对肾小管-间质病变的诊断价值[J].中国实用内科杂志,1999,19(4)：198-199
[27]李才.人类疾病动物模型的复制[M].北京：人民卫生出版社,2008：58
[28]Quaranta N, Fernandez-Vega Feijoo S, Piazza F, et al. Closed tympanoplasty in cholesteatoma surgery:long-term (10years) hearing results using cartilage ossiculoplasty [J]. Eur Arch Otorhinolaryngol,2001,258 (1):20
[29]王海燕.肾脏病学[M].北京：人民卫生出版社,2008：1777-1789
[30]王轶,王直中,曹克利.Alport综合症[J].听力学及言语疾病杂志,1999,7(4)：214-216
[31]王秋菊,韩东一,翟所强,等.遗传性听力损失及其综合症[J].北京：人民军医出版社,2006：391-542
[32]Kemperman MH, Koch SM, Joosten FB, et al. Inner ear anomalies are frequent but nonobligatory features of the branchio-oto-renal syndrome [J]. Arch Otolaryngol Head Neck Surg,2002,128 (9):1033-1038
[33]陶雅非,刘永革,任东升.慢性肾功能不全患者听力损伤的观察[J].河南大学学报(医学科学版),2002,21(1)：48
[34]李松杨,林顺涨,赵德美.尿毒症患者听力状况的临床研究[J].中国血液净化,2003,2(4)：180-182
[35]黄雯,郭连生,陈秀伍,等.肾脏病患者与听力损伤相关性的研究[J].耳鼻咽喉-头颈外科,2002,9(4)：203-206
[36]梁莹,屈欢欢,全春梅,等.慢性肾脏病患者耳鸣耳聋患病率及临床特点调查[J].中国中西医结合肾病杂志,2012,13(1)：38-39
[37]孙国华,刘少锋,范畴,等.慢性肾衰听功能损害动物模型的制备[J].听力学及言语疾病杂志,2006,14(2)：132-133
[38]王永华,刘旺,刘金洪.慢性肾衰竭对听力的影响及其机理研究[J].浙江中医药大学学报,2006,30(2)：183-188
[39]肖娟,罗志强.肾脏疾病与耳聋相关性[J].国际耳鼻喉头颈外科杂志,2007,31(6)：351-353
[40]陆丽明,曾境纯,李盈.“肾开窍于耳”与“心寄窍于耳”的对比研究[J].中医药通报,2008,7(2)：32-34
[41]陈慧娟,朱凌凌,石晓兰.“体华窍”理论指导从肾辨治疾病意义探讨[J].北京中医药大学学报,2011,34(10)：660
[42]李其忠,窦志芳.中医形体官窍理论与临床研究[M].上海科学技术出版社,2012：185
[43]师双斌,郑洪新.肾精盛衰的外在征象[J].中国中医基础医学杂志,2012,18(9)：941
[44]李瀚旻.“肾藏精”的科学内涵[J].中医杂志,2009,50(12)：1061-1065
[45]王琦.中医藏象学[M](第2版).北京：人民卫生出版社,2009：659
[46]梅全喜.简明实用中药药理手册[M].北京：人民卫生出版社2010：409-410
[47]宋琦,周亚滨.中药山茱萸药理作用研究进展[J].中医药信息 2006,2(2)：24-25
[48]张云芳,将孟良.山药的药理作用于炮制工艺研究进展[J].实用药物与临床,2012,15(1)：49-51
[49]周晶,李光华,枸杞的化学成分与药理作用研究概述[J].辽宁中医药大学学报,2009,11(6)：93-94
[50]朱玲,罗颂平,许丽绵,等.左归丸对卵巢早衰小鼠免疫功能的影响[J].中华中医药学刊,2008,2(6)：1157-1160
[51]鞠大宏,赵宏艳,刘梅洁,等.左归丸含药血清对成骨细胞IL-1、IL-6和COX-2表达的影响[J].中国实验动物学报,2006,14(2)：96-99
[52]戴薇薇,金国琴,张学礼,等.左归丸、右归丸对老年大鼠海马、杏仁核氨基酸类和单胺类神经递质含量变化的影响[J].中国老年学杂志,2006,26(8)：1066-1069
[53]夏华英,张江虹,谢月霞,等.补肾方药对D-半乳糖致衰大鼠心肌组织氧化应激和细胞凋亡的影响[J].辽宁中药杂志,2012,39(9)：1859-1861
[54]姚成芳,王丽,蔡生业,等.阴虚阳亢小鼠Th1/Th2类细胞因子的漂移现象及中药左归丸的干预研究研究[J].山东大学学报(医学版),2004,42(3)：349-352
[55]刘梅洁,吕国红,邹军,等.左归丸含药血清对成骨细胞分泌骨钙素的影响[J].中国中医基础医学杂志,2007,13(8)：581-582
[56]赵刚,蔡定芳,范钰,等.左归丸对老年大鼠大脑皮质8-羟基脱氧乌苷酸的调节作用[J].复旦学报(医学版),2002,29(3)：208-210
[57]龚张斌,徐品初,金国琴.左归丸对大鼠胸腺细胞凋亡及Bc1-2,Bax表达的影响[J].中国老年学杂志,2010,30(11)：3290-3292
[58]Bennett BL, Sasaki DT, Murray BW, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase[J]. Proc Natl Acad Sci USA,2001,98 (24):13681-13686
[59]Chang L, Karin M. Mammalian MAP kinase signalling cascades [J]. Nature,2001,410(6824):37-40
[60]Weston CR, Davis RJ. The JNK signal t ransduct ion pathway [J]. CurrOpin Ce 11 Biol,2007,19 (2):142-149
[61]Manning AM, Davis RJ. Targeting JNK for therapeutic benefit:from junk to gold [J]? Nat Rev Drug Discov,2003,2(7): 554-565
[62]Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway:regulation, function and role in human disease [J].Biochim Biophys Acta-Mol Cell Res,2007,1773(8):1341-1348
[63]Sykiotis GP, Bohmann D. Stress-Activated Protein Kinases, Heidelberg [J]. Springer Berlin,2008,225-241
[64]Dougherty CJ, Kubasiak LA, Frazier DP, et al. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation[J]. FASEBJ 2004,18 (10):1060-1070
[65]Fleming Y, Armstrong CG, Morrice N, et al. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activeted protein kinase kinase 4 (MKK4) and MKK7[J]. Biochem J 2000, 15:145-154
[66]Wang J, Chen L, Ko CI, et al. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation [J]. J Biol Chem,2012,287(4):2787-2797
[67]Tournier C, Dong C, Turner TK, et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinf lammatory cytokines [J]. Genes Dev 2001,15 (11):1419-1426
[68]侯炳旭,冯丽英.JNK信号通路介导的凋亡在疾病中的作用[J].世界华人消化杂志,2011,19(17)：1819-1824
[69]Davis RJ. Signal transduction by the JNK group of MAP kinases [J]. Cell,2000,103 (2):239-252
[70]Guan QH, Pei DS, Zhang QG, et al.The neuroprotective action of Sp600125, a new inhibitor of JNK, on transient brain is chemia/reperfus ion-induced neuronal death in rat hippocampal CA1 vianuclear and non-nuclear pathways [J]. Brain Res,2005,1035 (1):51
[71]黎增辉,廖爱军.JNK信号通路[J].国际病理科学与临床杂志,2010,30(3)273-276
[72]刘慧,唐胜松.JNK活化机制的研究进展[J].现代生物医学展,2008,5(7)1188-1190
[73]Carboni S, Antonsson B, Gail lard P, et al. Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient [J]. J Neurochem 2005,92(5):1054-1060
[74]Taleb M, Brandon CS, Lee FS, et al. Hsp70 inhibits aminoglycoside-induced hair cell death and is necessary for the protective effect of heat shock [J]. J Assoc Res Otolaryngol,2008,9 (3):277-289
[75]邱晓晓,戴雍月,宋张娟,等.SP600125对大鼠肺缺血/再灌注损伤的保护作用及机制[J].中国应用生理学杂志,2012,28(3)：255-258
[76]Dinh CT, Van De Water TR. Blocking pro-cell-death signal pathways to conserve hearing[J]. Audiol Neurootol, 2009,14(6):383-392
[77]赵翠娟,王承党.c-Jun氨基末端激酶选择性抑制剂对葡聚糖硫酸钠诱导的小鼠结肠炎的影响[J].世界华人消化杂志,2011,19(5)：515-518
[78]宋孟龙,唐晋,张献全,等.SP600125对急性一氧化碳中毒大鼠的脑保护作用[J].西部医学,2010,22(6)：991-993
[79]Francescato HD, Costa RS, Junior FB, et al. Effect of JNK inhibition on cisplatin-induced renal damage[J]. Nephrol Dial Transplant,2007,22 (8):2138-2148
[80]姜学钧,李巍,臧洪瑞,等.磷酸化JNK在庆大霉素致豚鼠前庭毛细胞凋亡中的表达[J].临床耳鼻咽喉科杂志,2005,19(19)：886-889
[81]臧洪瑞,姜学钧,任树北,等.JNK在豚鼠丁胺卡那霉素中毒后耳蜗毛细胞的激活表达[J].中国医科大学学报,2003,32(6)：508-510
[82]刘双月,王爱梅,许涛.阿米卡星对豚鼠耳蜗毛细胞磷酸化.JNK表达的影响[J].中国老年学杂志,2011,31(4)：1209-1211
[83]周彬,徐平,李艳,等.JNK抑制剂CEP-1347对噪声损伤耳蜗的保护作用及意义[J].山东大学耳鼻喉眼学报,2010,24(4)：25-28
[84]Francis SP, Kramarenko II, Brandon CS, et al. Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32 [J]. Cell Death Disease,2011,25 (2):1-11
[85]Taleb M, Brandon CS, Lee FS, et al. Hsp70 inhibits a minoglycoside-induced hearing loss and cochlear hair cell death [J]. Cell Stress Chaperones,2009,14 (4):427-437
[86]Nakamagoe M, Tabuchi K, Uemaetomari I, et al. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway [J]. Hear Res,2010,261 (2):67-74
[87]Wang J, Ruel J, Ladrech S, et al. Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals [J]. Mol Pharmacol,2007,71 (3):654-666
[88]朱家军,夏安周,王妍妍,等.银杏总黄酮对肾缺血再灌注大鼠p-JNK表达的影响[J].中国临床医药杂志,2011,15(3)：11-14
[89]李丹,张艳华,陈少杰,等.大鼠缺血-再灌注后JNK mRNA及蛋白表达的变化及银杏达莫注射液的干预作用[J].中国中西医结合肾病杂志,2011,12(4)：303-307
[90]Elsherbiny NM, Abd El Galil KH, Gabr MM, et al. Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1[J]. Eur Cytokine Netw, 2012,23 (3):78-86
[91]蓝灵,王美美.JNK在cGVHD狼疮样小鼠组织表达及在肾纤维化中作用研究[J].东南大学学报(医学版),2009,28(2)：90-95
[92]Lim BJ, Jeong JY, Chang YK,et al. C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice[J]. Ren Fail,2012, 34 (7):892-900
[93]Francescato HD, Coimbra TM, Costa RS, et al. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis [J]. Kidney Blood Press Res,2004,27 (3):148-158
[94]Kanellis J, Ma FY, Kandane-Rathnayake R, et al. JNK signaling in human and experimental renal ischaemia/reperfusion injury [J].Nephrol Dial Transplant,2010,25 (9):2898-2908
[95]薛秋红,陈佳,龚树生,等.JNK信号通道在强噪声诱导豚鼠耳蜗细胞凋亡的作用[J].临床耳鼻咽喉头颈外科杂志,2009,2(12)：1138-1142
[96]王艳,姬怀雪,邢淑华.金纳多对肾缺血/再灌注诱导的肾小管上皮细胞凋亡的影响[J].中国药理学通报,2007,23(8)：1093-1097
[1]李其忠,窦志芳.中医形体官窍理论与临床研究[M].上海科学技术出版社,2012：182
[2]师双斌,郑洪新.肾精盛衰的外在征象[J].中国中医基础医学杂志,2012,18(9)：941
[3]苏秀芳,赵利平.补肾益气活血汤治疗老年性耳鸣、耳聋90例[J].山西中医,2012,28(2)：17
[4]李莉,李卫华,毋桂花.固肾培元方治疗老年性聋临床观察[J]..辽宁中医药大学学报,2012,14(7)：111-112
[5]王枫,赵乌兰.补肾方对豚鼠耳蜗螺旋神经节凋亡基因表达的影响[J]..时珍国医国药,2010,21(1)：103-104
[6]李群真,宋永玲,许琳,等.补肾活血通窍中药复方对庆大霉素耳中毒小鼠耳蜗NT-3表达的影响[J].听力学及言语疾病杂志,2010,18(2)：160-163
[7]罗卫芳,郭树仁,程士德.中医学肾本质现代研究概述[J].中国中医基础医学杂志,2001,7(4)：315-316
[8]曾兆麟,吴大正,陆元元.中医“肾”与耳关系的实验研究[J].上海中医药杂志,1980,(1)2-5
[9]曾兆麟,张美莉,胡寿铭,等.从甲状腺激素对耳功能的影响看中医“肾”与耳的关系[J].上海中医药杂志,1988,(9)：2-4
[10]刘鲁明.试从钙、磷代谢角度探讨肾虚耳鸣的物质基础[J].中西医结合杂志,1996,(9)：538-539
[11]孙爱华,等.肾主耳理论的生化物质基础-缺铁大鼠肾虚证与内耳铁含量含铁酶变化[J].中医杂志,1991,(3)：44
[12]Garcia Berrocal JR, Remirez-Camacho R. Immune response and immunopathology of the inner ear:an update [J]. J Laryngol Otol,2000,114:101-107
[13]陈婷,张榕.水道蛋白在内淋巴囊和肾脏的表达及加压素对水道蛋白表达的影响[J].中华耳鼻咽喉科这种,2004,39(5)：273-277
[14]谭杰,张榕.大鼠内淋巴囊与肾脏集合管神经分布研究[J].中华耳鼻喉头颈外科杂志,2007,42(8)：603-607
[15]潘敏,王伟铭,陈楠.肾脏损伤和听力障碍-耳肾综合症[J].中华肾脏病杂志,2009,25(6)：487-490
[16]王海燕.肾脏病临床概览[M].北京：北京大学医学出版社,2010：425
[17]梁莹,屈欢欢,全春梅,等.慢性肾脏病患者耳鸣耳聋患病率及临床特点调查[J].中国中西医结合肾病杂志,2012,13(1)：38-39
[18]朱思亮,陆琦,黄向东.慢性肾功能衰竭患者脑干听觉电位的变化[J].江西医药,2003,3(1)：56-57
[19]黄雯,郭连生,陈秀伍,等.肾脏病患者与听力损伤相关性的研究[J].耳鼻咽喉-头颈外科,2002,9(4)：203-206
[20]王永华,刘旺,刘金洪.慢性肾衰竭对听力的影响及其机理研究[J].浙江中医药大学学报,2006,30(2)：183-188
[21]秦玉红,孙月华,翟立群,等.慢性肾功能不全血液透析患者的高频纯音听阈检测[J].临床耳鼻咽喉科杂志,2005,19(1)：17-18
[22]安玉香,苏禄晖,李舒音,等.粉防已碱拮抗豚鼠水杨酸急性耳肾损伤的实验研究[J].中国病理生理杂志,2003,19(11)：1569
[23]王东方,干祖望,苏长青,等.金匮肾气丸对庆大霉素肾和耳损害保护作用组织病理学研究[J].南京中医药大学学报,1998,14(5)：278-279
[1]Hibi M, Lin A, Smeal T, et al. Identification of an oncoprotein and UV responsive protein kinase that binds and potentiates the c-Jun activation domain[J]. Genes Dev,1993,7 (11): 2135-2148
[2]Weston CR, Davis RJ. The JNK signal transduction pathway [J]. CurrOpin Cell Biol,2007,19 (2):142-149
[3]Vallerie SN, Hotamisligil GS. The role of JNK proteins in metabolism[J]. Sci Transl Med,2010,12(60):60-65
[4]Davies C, Tournier C. Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies [J]. Biochem Soc Trans,2012,40(1):85-89
[5]Meng Q, Xia Y. c-Jun, at the crossroad of the signaling network [J]. Protein Cell,2011,2 (11):889-98
[6]Lawrence MC, Jivan A, Shao C, et al. The roles of MAPKs in disease[J]. Cell Res,2008,18 (4):436-442
[7]Davies C, Tournier C. Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies [J]. Biochem Soc Trans,2012,40(1):85-89
[8]Haeusgen W, Herdegen T, Waetzig V. The bottleneck of JNK signaling:molecular and functional characteristics of MKK4 and MKK7 [J]. Eur J Cell Biol,2011,90(6-7):536-544
[9]Kim EK, Choi EJ. Pathological roles of MAPK signaling path-ways in human diseases [J]. Biochim Biophys Acta,2010,1802 (4):396-405
[10]Sabapathy K. Role of the JNK pathway in human diseases [J]. Prog Mol Biol Transl Sci,2012,106:145-169
[11]Engstram W, Ward A, Moorwood K. The role of scaffold proteins in JNK signalling[J]. Cell Prolif,2010,43(1):56-66
[12]Bogoyevitch MA, Arthur PG. Inhibitors of c-Jun N-terminal kinases:JuNK no more[J]? Biochim Biophys Acta,2008,1784 (1):76-93
[13]Carboni S, Boschert U, Gaillard P, et al. AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils [J]. Br J Pharmacol,2008,153(1):157-163
[14]Colombo A, Repici M, Pesaresi M, et al. The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability [J]. Cell Death Differ,2007,14 (10):1845-1848
[15]Eggert D, Dash PK, Gorantla S, et al. Neuroprotective activities of CEP-1347 in models of neuroAIDS[J]. J Immunol, 2010,184(2):746-56
[16]Touchard E, Omri S, Naud MC, et al. A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis[J]. Invest Ophthalmol Vis Sci,2010,51(9): 4683-4693
[17]Wang D, Fu Q, Zhou Y, et al.β2 adrenergic receptor protein kinase, A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer's disease models[J]. J Biol Chem,2013 Feb 19 Epub ahead of print
[18]Zheng JC, Huang Y, Tang K, et al. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-lbeta and TNF-alpha:involvement of mitogen-activated protein kinases and protein kinase R[J]. J Neuroimmunol,2008,200(1-2):100-110
[19]Wang G, Pan J, Chen SD. Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease[J]. Prog Neurobiol,2012,98 (2):207-221
[20]Dou J, Li X, Cai Y, et al. Human cytomegalovirus induces caspasedependent apoptosis of megakaryocytic CHRF-288-11 cells by activating the JNK pathway [J]. Int J Hematol,2010,91 (4):620-629
[21]Sun L, Isaak CK, Zhou Y, et al. Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis[J]. Life Sci,2012,91(5-6):151-158
[22]Ocuin LM, Zeng S, Cavnar MJ, et al. Nilotinib protects the murine liver from ischemia/reperfusion injury [J]. J Hepatol, 2012,57 (4):766-773
[23]Qi D, Liu H, Niu J, et al. Heat shock protein 72 inhibits c-Jun N-terminal kinase 3 signaling pathway via Aktl during cereb-ral ischemia [J]. J Neurol Sci,2012,317 (1-2):123-129
[24]Nagashima R, Yamaguchi T, Tanaka H, et al. Mechanism underl-ying the protective effect of tempol and N ω-nitro-L-arginine methyl ester on acoustic injury:possible involvement of c-Jun N-terminal kinase pathway and connexin 26 in the cochlear spiral ligament [J]. J Pharmacol Sci,2010, 114(1):50-62
[25]Infante EB, Channer GA, Telischi FF, et al. Mannitol protects hair cells against tumor necrosis factor α-induced loss [J]. Otol Neurotol,2012,33(9):1656-1663
[26]Choi BM, Chen XY, Gao SS, et al. Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells [J]. Pharmacol Rep,2011,63(3):708-716
[27]Shim HJ, Kang HH, Ahn JH, et al. Retinoic acid applied after noise exposure can recover the noise-induced hearing loss in mice[J]. Acta Otolaryngol,2009,129 (3):233-238
[28]Meng LQ, Tang JW, Wang Y, et al. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy[J]. Br J Pharmacol,2011,162 (8):1805-1818
[29]Kanellis J, Ma FY, Kandane-Rathnayake R, et al. JNK signaling in human and experimental renal ischaemia/reperfusion injury[J]. Nephrol Dial Transplant,2010,25 (9):2898-2908
[30]Wang Y, Pei DS, Ji HX, et al. Protective effect of a standardized Ginkgo extract (ginaton) on renal ischemia/ reperfusion injury via suppressing the activation of JNK signal pathway [J]. Phytomedicine,2008,15 (11):923-931
[31]Lim BJ, Jeong JY, Chang YK, et al. C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice[J]. Ren Fail, 2012,34 (7):892-900
[32]Qi W, Mu J, Luo ZF, et al. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response [J]. Metabolism,2011,60(5):594-603
[33]Mitsios N, Gaffney J, Krupinski J, et al. Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue[J]. Cell Biochem Biophys 2007,47 (1):73-86
[34]Baker AR, Harte AL, Howell N, et al. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease [J]. J Clin Endocrinol Metab 2009,94 (1):261-267
[35]Kluwe J, Pradere JP, Gwak GY, et al. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition [J]. Gastroe-nterology 2011,138 (1):347-359
[36]Ferreira DM, Castro RE, Machado MV, et al. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease[J]. Diabetologia, 2011,54 (7):1788-1798
[37]Liu W, Liang Q, Balzar S, et al. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways[J]. J Allergy Clin Immunol,2008,121 (4):893-902
[38]Rumora L, Milevoj L, Popovic S, et al. Levels changes of blood leukocytes and intracellular signalling pathways in COPD patients with respect to smoking attitude[J]. Clin Biochem, 2008,41 (6):387-394
[39]Molad Y, Amit-Vasina M, Bloch 0, et al. Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythem tosus[J]. Ann Rheum Dis,2010,69 (1):175-180
[2]薛秋红,陈佳,龚树生,等.JNK信号通道在强噪声诱导豚鼠耳蜗细胞凋亡的作用[J].临床耳鼻咽喉头颈外科杂志,2009,24：1138-1142
[3]Meng LQ, Tang JW, Wang Y, et al. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy[J]. Br J Pharmacol,2011,162 (8):1805-1818
[4]李嫚,王汉民,李苏童,等.缺血后处理对大鼠肾脏缺血再灌注损伤P38MAPK和JNK的影响[J].医学临床研究,2008,25(7)：1170-1173
[5]Hou X, Shen YH, Li C, et al. PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity[J]. Biochem Biophys Res Commun, 2010,394(3):653-659
[6]Ohashi N, Urushihara M, Satou R, et al. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygenspecies-ERK/JNK pathways [J]. Hypertens Res,2010,33(11):1174-1181
[7]王小琴,袁军,马晓红,等.左归丸对5/6肾大部切除模型并肾性骨病大鼠骨代谢指标的影响[J].中国中西医结合肾病杂志,2012,13(7)：584-586
[8]贾琳琳,杨浩,付纯芳,等.刺五加注射液对豚鼠庆大霉素耳毒性拮抗作用的初步研究[J].中成药,2008,30(5)：763
[9]王枫,赵乌兰,黄宇佳.补肾剂对耳聋豚鼠耳蜗细胞凋亡的影响[J].浙江中医药大学学报,2008,32(4)：438
[10]王爱梅,杨浩,宝东艳,等.丹参注射液对庆大霉素耳中毒豚鼠耳蜗NOS异构体表达的影响[J].中国应用生理学杂志,2011,27,(2)：247
[11]Ozbek E, Cekmen M, Ilbey YO, et al. Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways[J]. Renal Failure,2009,31 (5):381-392
[12]陈香美.肾脏病学实验技术操作规程[M].北京：人民军医出版社,2011：197
[13]李荣山.现代肾脏病实验技术[M].北京：军事医学科学出版社,2006：103-104
[14]刘冬娟,赖亚新,徐彦平,等.庆大霉素致大鼠肾近端小管上皮细胞凋亡的超微结构研究[J].中国药物警戒,2009,6(12)：709-712
[15]延瑞喆.简述药物引起的耳毒性及防治措施[J].中国药事,2012,26(12)：1416
[16]Xie J, Talaska AE, Schacht J. New developments In aminogl-ycoside therapy and ototoxicity [J]. Hearing Research,2011, 281 (1-2):28-37
[17]Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycosid-e ototoxicity and targets of hair cell protection[J]. Int J Otolaryngol,2011:1-19
[18]丁大连,亓卫东,张梅,等.顺铂及其耳毒性[J].中华耳科学杂志,2008,6(2)：125-133
[19]薛翔,宫丽崑,任进.药物性肾损伤机制研究进展[J].药学学报,2010,45(10)：1199-1204
[20]李昱,王爱梅.氨基糖甙类抗生素耳毒性的研究进展[J].医学综述, 2008,14(3)：459-461
[21]Forge A, Schacht J. Aminoglyciside antibiotics [J]. Audiol Neuro-otol,2000,5(1):3-2
[22]高文元,迟放鲁.临床听觉生理学[M].北京：人民军医出版社,2004：236
[23]Karasawa T, Wang Q, David LL, et al. CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity[J]. Cell Death Dis,2010,1(11):102
[24]孔维佳.耳鼻咽喉头颈外科学[M].北京：人民卫生出版社,2008：162
[25]李兴启.听觉诱发反应及应用[M].北京：人民军医出版社,2007：122
[26]叶任高,许韩师.尿溶菌酶和N-乙酰-β-D-氨基葡萄糖苷酶测定对肾小管-间质病变的诊断价值[J].中国实用内科杂志,1999,19(4)：198-199
[27]李才.人类疾病动物模型的复制[M].北京：人民卫生出版社,2008：58
[28]Quaranta N, Fernandez-Vega Feijoo S, Piazza F, et al. Closed tympanoplasty in cholesteatoma surgery:long-term (10years) hearing results using cartilage ossiculoplasty [J]. Eur Arch Otorhinolaryngol,2001,258 (1):20
[29]王海燕.肾脏病学[M].北京：人民卫生出版社,2008：1777-1789
[30]王轶,王直中,曹克利.Alport综合症[J].听力学及言语疾病杂志,1999,7(4)：214-216
[31]王秋菊,韩东一,翟所强,等.遗传性听力损失及其综合症[J].北京：人民军医出版社,2006：391-542
[32]Kemperman MH, Koch SM, Joosten FB, et al. Inner ear anomalies are frequent but nonobligatory features of the branchio-oto-renal syndrome [J]. Arch Otolaryngol Head Neck Surg,2002,128 (9):1033-1038
[33]陶雅非,刘永革,任东升.慢性肾功能不全患者听力损伤的观察[J].河南大学学报(医学科学版),2002,21(1)：48
[34]李松杨,林顺涨,赵德美.尿毒症患者听力状况的临床研究[J].中国血液净化,2003,2(4)：180-182
[35]黄雯,郭连生,陈秀伍,等.肾脏病患者与听力损伤相关性的研究[J].耳鼻咽喉-头颈外科,2002,9(4)：203-206
[36]梁莹,屈欢欢,全春梅,等.慢性肾脏病患者耳鸣耳聋患病率及临床特点调查[J].中国中西医结合肾病杂志,2012,13(1)：38-39
[37]孙国华,刘少锋,范畴,等.慢性肾衰听功能损害动物模型的制备[J].听力学及言语疾病杂志,2006,14(2)：132-133
[38]王永华,刘旺,刘金洪.慢性肾衰竭对听力的影响及其机理研究[J].浙江中医药大学学报,2006,30(2)：183-188
[39]肖娟,罗志强.肾脏疾病与耳聋相关性[J].国际耳鼻喉头颈外科杂志,2007,31(6)：351-353
[40]陆丽明,曾境纯,李盈.“肾开窍于耳”与“心寄窍于耳”的对比研究[J].中医药通报,2008,7(2)：32-34
[41]陈慧娟,朱凌凌,石晓兰.“体华窍”理论指导从肾辨治疾病意义探讨[J].北京中医药大学学报,2011,34(10)：660
[42]李其忠,窦志芳.中医形体官窍理论与临床研究[M].上海科学技术出版社,2012：185
[43]师双斌,郑洪新.肾精盛衰的外在征象[J].中国中医基础医学杂志,2012,18(9)：941
[44]李瀚旻.“肾藏精”的科学内涵[J].中医杂志,2009,50(12)：1061-1065
[45]王琦.中医藏象学[M](第2版).北京：人民卫生出版社,2009：659
[46]梅全喜.简明实用中药药理手册[M].北京：人民卫生出版社2010：409-410
[47]宋琦,周亚滨.中药山茱萸药理作用研究进展[J].中医药信息 2006,2(2)：24-25
[48]张云芳,将孟良.山药的药理作用于炮制工艺研究进展[J].实用药物与临床,2012,15(1)：49-51
[49]周晶,李光华,枸杞的化学成分与药理作用研究概述[J].辽宁中医药大学学报,2009,11(6)：93-94
[50]朱玲,罗颂平,许丽绵,等.左归丸对卵巢早衰小鼠免疫功能的影响[J].中华中医药学刊,2008,2(6)：1157-1160
[51]鞠大宏,赵宏艳,刘梅洁,等.左归丸含药血清对成骨细胞IL-1、IL-6和COX-2表达的影响[J].中国实验动物学报,2006,14(2)：96-99
[52]戴薇薇,金国琴,张学礼,等.左归丸、右归丸对老年大鼠海马、杏仁核氨基酸类和单胺类神经递质含量变化的影响[J].中国老年学杂志,2006,26(8)：1066-1069
[53]夏华英,张江虹,谢月霞,等.补肾方药对D-半乳糖致衰大鼠心肌组织氧化应激和细胞凋亡的影响[J].辽宁中药杂志,2012,39(9)：1859-1861
[54]姚成芳,王丽,蔡生业,等.阴虚阳亢小鼠Th1/Th2类细胞因子的漂移现象及中药左归丸的干预研究研究[J].山东大学学报(医学版),2004,42(3)：349-352
[55]刘梅洁,吕国红,邹军,等.左归丸含药血清对成骨细胞分泌骨钙素的影响[J].中国中医基础医学杂志,2007,13(8)：581-582
[56]赵刚,蔡定芳,范钰,等.左归丸对老年大鼠大脑皮质8-羟基脱氧乌苷酸的调节作用[J].复旦学报(医学版),2002,29(3)：208-210
[57]龚张斌,徐品初,金国琴.左归丸对大鼠胸腺细胞凋亡及Bc1-2,Bax表达的影响[J].中国老年学杂志,2010,30(11)：3290-3292
[58]Bennett BL, Sasaki DT, Murray BW, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase[J]. Proc Natl Acad Sci USA,2001,98 (24):13681-13686
[59]Chang L, Karin M. Mammalian MAP kinase signalling cascades [J]. Nature,2001,410(6824):37-40
[60]Weston CR, Davis RJ. The JNK signal t ransduct ion pathway [J]. CurrOpin Ce 11 Biol,2007,19 (2):142-149
[61]Manning AM, Davis RJ. Targeting JNK for therapeutic benefit:from junk to gold [J]? Nat Rev Drug Discov,2003,2(7): 554-565
[62]Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway:regulation, function and role in human disease [J].Biochim Biophys Acta-Mol Cell Res,2007,1773(8):1341-1348
[63]Sykiotis GP, Bohmann D. Stress-Activated Protein Kinases, Heidelberg [J]. Springer Berlin,2008,225-241
[64]Dougherty CJ, Kubasiak LA, Frazier DP, et al. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation[J]. FASEBJ 2004,18 (10):1060-1070
[65]Fleming Y, Armstrong CG, Morrice N, et al. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activeted protein kinase kinase 4 (MKK4) and MKK7[J]. Biochem J 2000, 15:145-154
[66]Wang J, Chen L, Ko CI, et al. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation [J]. J Biol Chem,2012,287(4):2787-2797
[67]Tournier C, Dong C, Turner TK, et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinf lammatory cytokines [J]. Genes Dev 2001,15 (11):1419-1426
[68]侯炳旭,冯丽英.JNK信号通路介导的凋亡在疾病中的作用[J].世界华人消化杂志,2011,19(17)：1819-1824
[69]Davis RJ. Signal transduction by the JNK group of MAP kinases [J]. Cell,2000,103 (2):239-252
[70]Guan QH, Pei DS, Zhang QG, et al.The neuroprotective action of Sp600125, a new inhibitor of JNK, on transient brain is chemia/reperfus ion-induced neuronal death in rat hippocampal CA1 vianuclear and non-nuclear pathways [J]. Brain Res,2005,1035 (1):51
[71]黎增辉,廖爱军.JNK信号通路[J].国际病理科学与临床杂志,2010,30(3)273-276
[72]刘慧,唐胜松.JNK活化机制的研究进展[J].现代生物医学展,2008,5(7)1188-1190
[73]Carboni S, Antonsson B, Gail lard P, et al. Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient [J]. J Neurochem 2005,92(5):1054-1060
[74]Taleb M, Brandon CS, Lee FS, et al. Hsp70 inhibits aminoglycoside-induced hair cell death and is necessary for the protective effect of heat shock [J]. J Assoc Res Otolaryngol,2008,9 (3):277-289
[75]邱晓晓,戴雍月,宋张娟,等.SP600125对大鼠肺缺血/再灌注损伤的保护作用及机制[J].中国应用生理学杂志,2012,28(3)：255-258
[76]Dinh CT, Van De Water TR. Blocking pro-cell-death signal pathways to conserve hearing[J]. Audiol Neurootol, 2009,14(6):383-392
[77]赵翠娟,王承党.c-Jun氨基末端激酶选择性抑制剂对葡聚糖硫酸钠诱导的小鼠结肠炎的影响[J].世界华人消化杂志,2011,19(5)：515-518
[78]宋孟龙,唐晋,张献全,等.SP600125对急性一氧化碳中毒大鼠的脑保护作用[J].西部医学,2010,22(6)：991-993
[79]Francescato HD, Costa RS, Junior FB, et al. Effect of JNK inhibition on cisplatin-induced renal damage[J]. Nephrol Dial Transplant,2007,22 (8):2138-2148
[80]姜学钧,李巍,臧洪瑞,等.磷酸化JNK在庆大霉素致豚鼠前庭毛细胞凋亡中的表达[J].临床耳鼻咽喉科杂志,2005,19(19)：886-889
[81]臧洪瑞,姜学钧,任树北,等.JNK在豚鼠丁胺卡那霉素中毒后耳蜗毛细胞的激活表达[J].中国医科大学学报,2003,32(6)：508-510
[82]刘双月,王爱梅,许涛.阿米卡星对豚鼠耳蜗毛细胞磷酸化.JNK表达的影响[J].中国老年学杂志,2011,31(4)：1209-1211
[83]周彬,徐平,李艳,等.JNK抑制剂CEP-1347对噪声损伤耳蜗的保护作用及意义[J].山东大学耳鼻喉眼学报,2010,24(4)：25-28
[84]Francis SP, Kramarenko II, Brandon CS, et al. Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32 [J]. Cell Death Disease,2011,25 (2):1-11
[85]Taleb M, Brandon CS, Lee FS, et al. Hsp70 inhibits a minoglycoside-induced hearing loss and cochlear hair cell death [J]. Cell Stress Chaperones,2009,14 (4):427-437
[86]Nakamagoe M, Tabuchi K, Uemaetomari I, et al. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway [J]. Hear Res,2010,261 (2):67-74
[87]Wang J, Ruel J, Ladrech S, et al. Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals [J]. Mol Pharmacol,2007,71 (3):654-666
[88]朱家军,夏安周,王妍妍,等.银杏总黄酮对肾缺血再灌注大鼠p-JNK表达的影响[J].中国临床医药杂志,2011,15(3)：11-14
[89]李丹,张艳华,陈少杰,等.大鼠缺血-再灌注后JNK mRNA及蛋白表达的变化及银杏达莫注射液的干预作用[J].中国中西医结合肾病杂志,2011,12(4)：303-307
[90]Elsherbiny NM, Abd El Galil KH, Gabr MM, et al. Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1[J]. Eur Cytokine Netw, 2012,23 (3):78-86
[91]蓝灵,王美美.JNK在cGVHD狼疮样小鼠组织表达及在肾纤维化中作用研究[J].东南大学学报(医学版),2009,28(2)：90-95
[92]Lim BJ, Jeong JY, Chang YK,et al. C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice[J]. Ren Fail,2012, 34 (7):892-900
[93]Francescato HD, Coimbra TM, Costa RS, et al. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis [J]. Kidney Blood Press Res,2004,27 (3):148-158
[94]Kanellis J, Ma FY, Kandane-Rathnayake R, et al. JNK signaling in human and experimental renal ischaemia/reperfusion injury [J].Nephrol Dial Transplant,2010,25 (9):2898-2908
[95]薛秋红,陈佳,龚树生,等.JNK信号通道在强噪声诱导豚鼠耳蜗细胞凋亡的作用[J].临床耳鼻咽喉头颈外科杂志,2009,2(12)：1138-1142
[96]王艳,姬怀雪,邢淑华.金纳多对肾缺血/再灌注诱导的肾小管上皮细胞凋亡的影响[J].中国药理学通报,2007,23(8)：1093-1097
[1]李其忠,窦志芳.中医形体官窍理论与临床研究[M].上海科学技术出版社,2012：182
[2]师双斌,郑洪新.肾精盛衰的外在征象[J].中国中医基础医学杂志,2012,18(9)：941
[3]苏秀芳,赵利平.补肾益气活血汤治疗老年性耳鸣、耳聋90例[J].山西中医,2012,28(2)：17
[4]李莉,李卫华,毋桂花.固肾培元方治疗老年性聋临床观察[J]..辽宁中医药大学学报,2012,14(7)：111-112
[5]王枫,赵乌兰.补肾方对豚鼠耳蜗螺旋神经节凋亡基因表达的影响[J]..时珍国医国药,2010,21(1)：103-104
[6]李群真,宋永玲,许琳,等.补肾活血通窍中药复方对庆大霉素耳中毒小鼠耳蜗NT-3表达的影响[J].听力学及言语疾病杂志,2010,18(2)：160-163
[7]罗卫芳,郭树仁,程士德.中医学肾本质现代研究概述[J].中国中医基础医学杂志,2001,7(4)：315-316
[8]曾兆麟,吴大正,陆元元.中医“肾”与耳关系的实验研究[J].上海中医药杂志,1980,(1)2-5
[9]曾兆麟,张美莉,胡寿铭,等.从甲状腺激素对耳功能的影响看中医“肾”与耳的关系[J].上海中医药杂志,1988,(9)：2-4
[10]刘鲁明.试从钙、磷代谢角度探讨肾虚耳鸣的物质基础[J].中西医结合杂志,1996,(9)：538-539
[11]孙爱华,等.肾主耳理论的生化物质基础-缺铁大鼠肾虚证与内耳铁含量含铁酶变化[J].中医杂志,1991,(3)：44
[12]Garcia Berrocal JR, Remirez-Camacho R. Immune response and immunopathology of the inner ear:an update [J]. J Laryngol Otol,2000,114:101-107
[13]陈婷,张榕.水道蛋白在内淋巴囊和肾脏的表达及加压素对水道蛋白表达的影响[J].中华耳鼻咽喉科这种,2004,39(5)：273-277
[14]谭杰,张榕.大鼠内淋巴囊与肾脏集合管神经分布研究[J].中华耳鼻喉头颈外科杂志,2007,42(8)：603-607
[15]潘敏,王伟铭,陈楠.肾脏损伤和听力障碍-耳肾综合症[J].中华肾脏病杂志,2009,25(6)：487-490
[16]王海燕.肾脏病临床概览[M].北京：北京大学医学出版社,2010：425
[17]梁莹,屈欢欢,全春梅,等.慢性肾脏病患者耳鸣耳聋患病率及临床特点调查[J].中国中西医结合肾病杂志,2012,13(1)：38-39
[18]朱思亮,陆琦,黄向东.慢性肾功能衰竭患者脑干听觉电位的变化[J].江西医药,2003,3(1)：56-57
[19]黄雯,郭连生,陈秀伍,等.肾脏病患者与听力损伤相关性的研究[J].耳鼻咽喉-头颈外科,2002,9(4)：203-206
[20]王永华,刘旺,刘金洪.慢性肾衰竭对听力的影响及其机理研究[J].浙江中医药大学学报,2006,30(2)：183-188
[21]秦玉红,孙月华,翟立群,等.慢性肾功能不全血液透析患者的高频纯音听阈检测[J].临床耳鼻咽喉科杂志,2005,19(1)：17-18
[22]安玉香,苏禄晖,李舒音,等.粉防已碱拮抗豚鼠水杨酸急性耳肾损伤的实验研究[J].中国病理生理杂志,2003,19(11)：1569
[23]王东方,干祖望,苏长青,等.金匮肾气丸对庆大霉素肾和耳损害保护作用组织病理学研究[J].南京中医药大学学报,1998,14(5)：278-279
[1]Hibi M, Lin A, Smeal T, et al. Identification of an oncoprotein and UV responsive protein kinase that binds and potentiates the c-Jun activation domain[J]. Genes Dev,1993,7 (11): 2135-2148
[2]Weston CR, Davis RJ. The JNK signal transduction pathway [J]. CurrOpin Cell Biol,2007,19 (2):142-149
[3]Vallerie SN, Hotamisligil GS. The role of JNK proteins in metabolism[J]. Sci Transl Med,2010,12(60):60-65
[4]Davies C, Tournier C. Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies [J]. Biochem Soc Trans,2012,40(1):85-89
[5]Meng Q, Xia Y. c-Jun, at the crossroad of the signaling network [J]. Protein Cell,2011,2 (11):889-98
[6]Lawrence MC, Jivan A, Shao C, et al. The roles of MAPKs in disease[J]. Cell Res,2008,18 (4):436-442
[7]Davies C, Tournier C. Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies [J]. Biochem Soc Trans,2012,40(1):85-89
[8]Haeusgen W, Herdegen T, Waetzig V. The bottleneck of JNK signaling:molecular and functional characteristics of MKK4 and MKK7 [J]. Eur J Cell Biol,2011,90(6-7):536-544
[9]Kim EK, Choi EJ. Pathological roles of MAPK signaling path-ways in human diseases [J]. Biochim Biophys Acta,2010,1802 (4):396-405
[10]Sabapathy K. Role of the JNK pathway in human diseases [J]. Prog Mol Biol Transl Sci,2012,106:145-169
[11]Engstram W, Ward A, Moorwood K. The role of scaffold proteins in JNK signalling[J]. Cell Prolif,2010,43(1):56-66
[12]Bogoyevitch MA, Arthur PG. Inhibitors of c-Jun N-terminal kinases:JuNK no more[J]? Biochim Biophys Acta,2008,1784 (1):76-93
[13]Carboni S, Boschert U, Gaillard P, et al. AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils [J]. Br J Pharmacol,2008,153(1):157-163
[14]Colombo A, Repici M, Pesaresi M, et al. The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability [J]. Cell Death Differ,2007,14 (10):1845-1848
[15]Eggert D, Dash PK, Gorantla S, et al. Neuroprotective activities of CEP-1347 in models of neuroAIDS[J]. J Immunol, 2010,184(2):746-56
[16]Touchard E, Omri S, Naud MC, et al. A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis[J]. Invest Ophthalmol Vis Sci,2010,51(9): 4683-4693
[17]Wang D, Fu Q, Zhou Y, et al.β2 adrenergic receptor protein kinase, A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer's disease models[J]. J Biol Chem,2013 Feb 19 Epub ahead of print
[18]Zheng JC, Huang Y, Tang K, et al. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-lbeta and TNF-alpha:involvement of mitogen-activated protein kinases and protein kinase R[J]. J Neuroimmunol,2008,200(1-2):100-110
[19]Wang G, Pan J, Chen SD. Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease[J]. Prog Neurobiol,2012,98 (2):207-221
[20]Dou J, Li X, Cai Y, et al. Human cytomegalovirus induces caspasedependent apoptosis of megakaryocytic CHRF-288-11 cells by activating the JNK pathway [J]. Int J Hematol,2010,91 (4):620-629
[21]Sun L, Isaak CK, Zhou Y, et al. Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis[J]. Life Sci,2012,91(5-6):151-158
[22]Ocuin LM, Zeng S, Cavnar MJ, et al. Nilotinib protects the murine liver from ischemia/reperfusion injury [J]. J Hepatol, 2012,57 (4):766-773
[23]Qi D, Liu H, Niu J, et al. Heat shock protein 72 inhibits c-Jun N-terminal kinase 3 signaling pathway via Aktl during cereb-ral ischemia [J]. J Neurol Sci,2012,317 (1-2):123-129
[24]Nagashima R, Yamaguchi T, Tanaka H, et al. Mechanism underl-ying the protective effect of tempol and N ω-nitro-L-arginine methyl ester on acoustic injury:possible involvement of c-Jun N-terminal kinase pathway and connexin 26 in the cochlear spiral ligament [J]. J Pharmacol Sci,2010, 114(1):50-62
[25]Infante EB, Channer GA, Telischi FF, et al. Mannitol protects hair cells against tumor necrosis factor α-induced loss [J]. Otol Neurotol,2012,33(9):1656-1663
[26]Choi BM, Chen XY, Gao SS, et al. Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells [J]. Pharmacol Rep,2011,63(3):708-716
[27]Shim HJ, Kang HH, Ahn JH, et al. Retinoic acid applied after noise exposure can recover the noise-induced hearing loss in mice[J]. Acta Otolaryngol,2009,129 (3):233-238
[28]Meng LQ, Tang JW, Wang Y, et al. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy[J]. Br J Pharmacol,2011,162 (8):1805-1818
[29]Kanellis J, Ma FY, Kandane-Rathnayake R, et al. JNK signaling in human and experimental renal ischaemia/reperfusion injury[J]. Nephrol Dial Transplant,2010,25 (9):2898-2908
[30]Wang Y, Pei DS, Ji HX, et al. Protective effect of a standardized Ginkgo extract (ginaton) on renal ischemia/ reperfusion injury via suppressing the activation of JNK signal pathway [J]. Phytomedicine,2008,15 (11):923-931
[31]Lim BJ, Jeong JY, Chang YK, et al. C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice[J]. Ren Fail, 2012,34 (7):892-900
[32]Qi W, Mu J, Luo ZF, et al. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response [J]. Metabolism,2011,60(5):594-603
[33]Mitsios N, Gaffney J, Krupinski J, et al. Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue[J]. Cell Biochem Biophys 2007,47 (1):73-86
[34]Baker AR, Harte AL, Howell N, et al. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease [J]. J Clin Endocrinol Metab 2009,94 (1):261-267
[35]Kluwe J, Pradere JP, Gwak GY, et al. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition [J]. Gastroe-nterology 2011,138 (1):347-359
[36]Ferreira DM, Castro RE, Machado MV, et al. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease[J]. Diabetologia, 2011,54 (7):1788-1798
[37]Liu W, Liang Q, Balzar S, et al. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways[J]. J Allergy Clin Immunol,2008,121 (4):893-902
[38]Rumora L, Milevoj L, Popovic S, et al. Levels changes of blood leukocytes and intracellular signalling pathways in COPD patients with respect to smoking attitude[J]. Clin Biochem, 2008,41 (6):387-394
[39]Molad Y, Amit-Vasina M, Bloch 0, et al. Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythem tosus[J]. Ann Rheum Dis,2010,69 (1):175-180